Trial NCT01907100

View at ClinicalTrials.gov 
Org. Study IDs: 1199.93
Secondary IDs: 2012-005201-48

Last trial update was posted on 2019-03-18

MeSH Interventions

Cisplatin Nintedanib Pemetrexed

MeSH Conditions

Mesothelioma Mesothelioma, Malignant

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

In accordance with the specifications in the protocol, the trial was discontinued prematurely after the primary PFS analysis not because of any safety concerns but rather due to failure to meet the efficacy target.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID